Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up

Omega Diagnostics welcomes Covid-19 test verification

Wed, 5th May 2021

Disease testing group Omega Diagnostics welcomed news that its Mologic Covid-19 lateral flow antigen test has been independently verified in a 665-person study in Germany by FIND, a not-for-profit foundation. The test was shown to demonstrate best-in-class performance with 100% specificity and 96.4% sensitivity compared with laboratory PCR testing. Omega has CE-Marked the Mologic lateral flow antigen test for Covid-19 and has launched the test for professional-use under Omega's Visitect brand. Story provided by

FTSE 100 Latest